Adam Koppel
CIK 1578965 · EVP, Strategy and Bus. Dev. · last filed 2026-04-20
Adam Koppel is an EVP, Strategy and Bus. Dev. who has filed 64 SEC Form 4 insider transactions across 11 companies since 2013. The most recent filing, for KLRA, was dated Apr 20, 2026. Across all open-market trades the lifetime net is +$112.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $110.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$110.69M
11
64
$112.76M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRA | Director | 22,583,268 | — | — | $25.00M | 1 | 2026-04-20 |
| FHTX | Director | — | $4.18 | — | $0 | 4 | 2024-06-28 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 65,693,524 | $44.96 | $2.95B | $125.00M | 4 | 2024-06-07 |
| SLDB | Director | 4,034,582 | $7.14 | $28.81M | $4.80M | 13 | 2024-01-12 |
| Aptinyx Inc. (APTX) Delisted | Director | 5,558,425 | $0.06 | $339.1K | $16.40M | 10 | 2022-05-31 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 0 | $38.22 | $0 | -$180.42M | 10 | 2021-12-29 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | 60,632,356 | $18.07 | $1.10B | $103.42M | 3 | 2021-06-14 |
| BCLS Acquisition Corp. (BLSA) Delisted | Director | 487,500 | $10.04 | $4.89M | $0 | 1 | 2020-10-26 |
| TRVN | Director | — | $0.01 | — | $0 | 5 | 2018-05-17 |
| PTCT | Director | 1,083,333 | $75.14 | $81.40M | $18.75M | 5 | 2017-01-05 |
| BIIB | EVP, Strategy and Bus. Dev. | 2,402 | $200.05 | $480.5K | -$189.0K | 7 | 2016-06-07 |
Recent Filings
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-20 | KLRA | Mixed | +22,583,268 | $25.00M | EDGAR |
| 2024-08-05 | — | Disp (D) | −65,693,524 | $0 | |
| 2024-06-28 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | +10,461 | $0 | EDGAR |
| 2024-01-12 | SLDB | Grant (A) | +904,160 | $5.00M | EDGAR |
| 2023-10-18 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Buy (P) | +5,480,052 | $125.00M | EDGAR |
| 2023-06-22 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | −429,345 | $0 | EDGAR |
| 2023-06-08 | SLDB | Grant (A) | — | $0 | EDGAR |
| 2022-12-15 | SLDB | Grant (A) | — | $0 | EDGAR |